Hematology and Oncology
Home Hematology and Oncology
FDA Commissioner Dr. Scott Gottlieb Resigns
Gottlieb's signature effort has been tighter scrutiny, enforcement of e-cigarette industry
Higher Intake of Whole Grains May Lower Risk for Liver Cancer
Whole grains and possibly cereal fiber, bran appear linked to lower risk for hepatocellular carcinoma
Multidimensional Approach Cuts Unneeded Drug-Drug Interaction Alerts
Number of interruptive DDI alerts substantially decreased as result of alert refinement efforts
Readmission for Patients With Sepsis Common and Costly
Most readmissions associated with infectious etiologies, as well as GI, CV, pulmonary, renal causes
Low-Dose Aspirin Does Not Cut Death From Prostate Cancer
But during extended exposure periods of at least five years, low-dose aspirin may cut mortality
Breast Cancer Diagnosis Delays Seen With High-Deductible Health Plans
Delays observed in first breast imaging, biopsy, incident early-stage breast cancer diagnosis, chemo
February 2019 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for February 2019. This roundup includes...
Long-Term Cardiomyopathy Risk Varies by Chemo Agent
Decreased risk seen for daunorubicin versus doxorubicin among survivors of childhood cancer
HPV Infection Unlikely to Spread From Hand Contact
Risk for new infection largely due to partners' genital HPV infection, not virus detectable on hands
Liquid Biopsy-Based Test IDs Biomarkers in Metastatic NSCLC
Test led to increase in number of patients with identified G7 biomarker, reduction in turnaround time
